你不可能总能得到你想要的，但如果你偶尔尝试一下（用两种检测方法——结核菌素皮肤试验和γ-干扰素释放试验来检测结核病），你就能得到你所需要的。 - Suppr

Suppr

超能文献

You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.

作者信息

Winthrop Kevin L, Weinblatt Michael E, Daley Charles L

出版信息

Ann Rheum Dis. 2012 Nov;71(11):1757-60. doi: 10.1136/annrheumdis-2012-201979. Epub 2012 Sep 12.

DOI:10.1136/annrheumdis-2012-201979

PMID:22975752

Abstract

摘要

相似文献

You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.你不可能总能得到你想要的，但如果你偶尔尝试一下（用两种检测方法——结核菌素皮肤试验和γ-干扰素释放试验来检测结核病），你就能得到你所需要的。

Ann Rheum Dis. 2012 Nov;71(11):1757-60. doi: 10.1136/annrheumdis-2012-201979. Epub 2012 Sep 12.

Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.用体外干扰素 γ 释放试验替代结核菌素皮肤试验对接受抗 TNF 治疗前预防性使用抗结核抗生素的决策的影响。

Ann Rheum Dis. 2012 Nov;71(11):1783-90. doi: 10.1136/annrheumdis-2011-200408. Epub 2012 Jan 17.

The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.

Ann Rheum Dis. 2012 Nov;71(11):1909-11. doi: 10.1136/annrheumdis-2012-201913. Epub 2012 Jul 17.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.在类风湿关节炎、银屑病关节炎或强直性脊柱炎患者中，使用人抗肿瘤坏死因子抗体戈利木单抗治疗前，γ干扰素释放试验与结核菌素皮肤试验的比较。

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.潜伏性结核感染筛查：结核菌素皮肤试验和干扰素-γ释放试验在实际条件下的表现。

Ann Rheum Dis. 2012 Nov;71(11):1791-5. doi: 10.1136/annrheumdis-2011-200941. Epub 2012 May 14.

Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.宿主因素与活动性肺结核患者干扰素-γ释放试验假阴性和不确定结果相关。

Pulmonology. 2020 Nov-Dec;26(6):353-362. doi: 10.1016/j.pulmoe.2019.11.001. Epub 2019 Dec 13.

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.挪威医护人员中潜伏性结核病的筛查：结核菌素皮肤试验阳性与干扰素-γ释放试验阴性结果不一致的高频率情况。

BMC Public Health. 2013 Apr 17;13:353. doi: 10.1186/1471-2458-13-353.

Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.比较葡萄牙两种潜伏性结核感染筛查策略的成本效益。

Pulmonology. 2021 Nov-Dec;27(6):493-499. doi: 10.1016/j.pulmoe.2021.04.002. Epub 2021 May 27.

Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.HIV感染患者中的结核病筛查：结核菌素皮肤试验与干扰素-γ释放试验

AIDS Care. 2017 Dec;29(12):1504-1509. doi: 10.1080/09540121.2017.1325438. Epub 2017 May 9.

Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.在香港有资格使用生物制剂的关节炎患者中，比较一种商用γ-干扰素释放试验和结核菌素皮肤试验用于检测潜伏性结核感染的情况。

Hong Kong Med J. 2017 Jun;23(3):246-50. doi: 10.12809/hkmj164880. Epub 2017 Jan 27.

引用本文的文献

Infection risk with JAK inhibitors in dermatoses: a meta-analysis.皮肤病中使用JAK抑制剂的感染风险：一项荟萃分析。

Int J Dermatol. 2025 Jan;64(1):24-36. doi: 10.1111/ijd.17501. Epub 2024 Oct 4.

Latent Tuberculosis Infection Management in Solid Organ Transplantation Recipients: A National Snapshot.实体器官移植受者的潜伏性结核感染管理：全国概况

Thorac Res Pract. 2024 May;25(3):130-135. doi: 10.5152/ThoracResPract.2024.23110..

Detecting tuberculosis in pregnant and postpartum women in Eswatini.在斯威士兰检测孕妇和产后妇女的结核病。

Afr J Lab Med. 2020 Jul 30;9(1):837. doi: 10.4102/ajlm.v9i1.837. eCollection 2020.

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies.靶向合成疗法时代类风湿关节炎患者的感染

Mediterr J Rheumatol. 2020 Jun 11;31(Suppl 1):129-136. doi: 10.31138/mjr.31.1.129. eCollection 2020 Jun.

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment.长期生物治疗下风湿病患者及基线筛查阴性患者的结核病筛查检测的转化率和逆转率

Pathog Immun. 2020 Feb 26;5(1):34-51. doi: 10.20411/pai.v5i1.349. eCollection 2020.

Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review.实体器官移植候选者和接受者中结核病的管理与诊断：专家调查及最新综述

J Clin Tuberc Other Mycobact Dis. 2018 Apr 10;11:37-46. doi: 10.1016/j.jctube.2018.04.001. eCollection 2018 May.

Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.科威特风湿病学会 2018 年类风湿关节炎患者治疗建议。

Rheumatol Int. 2019 Sep;39(9):1483-1497. doi: 10.1007/s00296-019-04372-y. Epub 2019 Jul 15.

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?生物制剂治疗类风湿关节炎患者感染风险预测：我们离风险分层更近了吗？

Curr Opin Rheumatol. 2019 May;31(3):285-292. doi: 10.1097/BOR.0000000000000598.

Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.结核感染 T 细胞检测试剂盒（酶联免疫斑点法），一种新一代干扰素γ释放分析试剂的特异性。

J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.00629-18. Print 2018 Dec.

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.比较肿瘤坏死因子抑制剂治疗前炎症性关节炎潜伏性结核感染筛查策略：IGRA 单独与 TST 和 IGRA 联合。

PLoS One. 2018 Jul 5;13(7):e0198756. doi: 10.1371/journal.pone.0198756. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验